Application of proteomics in non-small-cell lung cancer.

摘要: Non-small-cell lung cancer (NSCLC) is a heterogeneous disease with diverse pathological features. Clinical proteomics allows the discovery of molecular markers and new therapeutic targets for this most prevalent type cancer. Some them may be used to detect early cancer, while others serve as predictive resistance different therapies. Therapeutic prognostic in NSCLC have also been discovered. These biomarkers help pair individual patient best treatment option. Despite fact that implementation these clinic appears scarce, recently launched Precision Medicine Initiative encourage their translation into clinical practice.